Abstract Objective To investigate the acceptance testing of the photon beam model in Axesse accelerator in Monaco and Oncentra treatment planning systems (TPS), in order to establish an integral method for the acceptance of both systems at the same time. Methods The conflicting parameters of the two TPSs were determined before acceptance, and the corresponding parameters in the accelerator were adjusted to the overlapping values. The acceptance test was performed from the aspects of point dose, surface dose, and characteristic simulation of multi-leaf collimator (MLC). The test case for point dose was designed based on TRS430, TG53, and practical situations. The test case for surface dose included conventional radiation field and intensity-modulated radiotherapy (IMRT) cases. The test of the characteristics of MLC included concave-convex groove, leakage, and values of"offset" and"Gain". Results The error of most point doses were within 4%, and only some measuring points in the penumbra region and outside the radiation field had an error of>4%. The γ pass rate of the surface dose tests and IMRT cases was>90% at a value of 3 mm/3% except three test cases. Oncentra could only simulate the situation with a positive offset value of MLC, but Monaco could simulate the situation with both positive and negative offset values of MLC. Conclusions The results show that this method can accurately validate all the parameters of the two systems and realize the accurate acceptance of Monaco and Oncentra systems with Axesse accelerator. Both Monaco and Oncentra models can meet the needs for clinical calculation.
Ma Yangguang,Liu lele,Wang fangna et al. Acceptance testing of photon beam model in Axesse accelerator in two intensity-modulated treatment planning systems[J]. Chinese Journal of Radiation Oncology, 2016, 25(7): 733-739.
Ma Yangguang,Liu lele,Wang fangna et al. Acceptance testing of photon beam model in Axesse accelerator in two intensity-modulated treatment planning systems[J]. Chinese Journal of Radiation Oncology, 2016, 25(7): 733-739.
[1]zgüven Y,Yaray K,Alkaya F,et al. An institutional experience of quality assurance of a treatment planning system on photon beam[J].Rep Pract Oncol Radiother,2014,19(3):195-205.DOI:10.1016/j.rpor.2013.10.008 [2]Fraass B,Doppke K,Hunt M,et al. American association of physicists in medicine radiation therapy committee task group 53:quality assurance for clinical radiotherapy treatment planning[J].Med Phys,1998,25(10):1773-1829.DOI:10.1118/1.598373 [3]International Atomic Energy Agency. Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer[R].Technical Report Series No.430.Vienna:IAEA,2004 [4]Venselaar J,Welleweerd H.Application of a test package in an intercomparison of the photon dose calculation performance of treatment planning systems used in a clinical setting[J].Radiother Oncol,2001,60(2):203-213.DOI:10.1016/S0167-8140(01)00304-8 [5]Venselaar J,Welleweerd H,Mijnheer B.Tolerances for the accuracy of photon beam dose calculations of treatment planning systems[J].Radiother Oncol,2001,60(2):191-201.DOI:10.1016/S0167-8140(01)00377-2 [6]符贵山,戴建荣,徐英杰,等.调强放疗计划系统的剂量学特性测试方法[J].中华放射肿瘤学杂志,2007,16(6):455-460.DOI:10.3760/j.issn:1004-4221.2007.06.012. Fu GS,Dai JR,Xu YJ,et al. Dosimetric commissioning for treatment planning system of intensity modulated radiation therapy module[J].Chin J Radiat Oncol,2007,16(6):455-460.DOI:10.3760/j.issn:1004-4221.2007.06.012 [7]Van Dyk J.Quality assurance of radiation therapy planning systems:current status and remaining challenges[J].Int J Radiat Oncol Biol Phys,2007,70(S1):S23-S27.DOI:10.1016/j.ijrobp.2007.04.095 [8]Camargo PRTL,Rodrigues LN,Furnari L,et al. Implementation of a quality assurance program for computerized treatment planning systems[J].Med Phys,2007,34(7):2827-2836.DOI:10.1118/1.2742779 [9]International Atomic Energy Agency. IAEA TECDOC 1540-2007 Specification and acceptance testing of radiotherapy treatment planning systems[R].IAEA,2007. [10]Monaco technical reference:post-modeling adjustment of MLC parameters[R].IMPAC Medical Systems Inc.,2012.